Amedisys, Inc. (AMED) — Financial statements
Income statement, balance sheet, and cash flow for Amedisys, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 2,348↑5.0% | 2,236↑0.6% | 2,223↑0.4% | 2,214↑6.9% | 2,072 | |
| Cost of Revenue | 1,331↑6.8% | 1,246↓1.2% | 1,260↑2.2% | 1,233↑4.0% | 1,185 | |
| Gross Profit | 1,018↑2.7% | 991↑2.9% | 963↓1.8% | 981↑10.7% | 886 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00↓100.0% | 4↑26.7% | 3 | 0.00 | 0.00 | |
| General & Administrative Expenses | 790↑199.3% | 264↓65.0% | 754↑6.0% | 711↑6.4% | 668 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 516 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 790↑1.3% | 780↑3.4% | 754↑6.0% | 711↑6.4% | 668 | |
| Other Expenses | 133↑162.8% | 51↑103.0% | 25↑41.7% | 18↑416.0% | -6 | |
| Operating Expenses | 923↑10.6% | 834↑7.1% | 779↑6.9% | 729↑10.0% | 663 | |
| Total Costs & Expenses | 2,254↑8.4% | 2,080↑2.0% | 2,039↑3.9% | 1,962↑6.2% | 1,848 | |
| Operating Results | ||||||
| Operating Income | 95↓39.6% | 156↓13.5% | 181↓28.2% | 252↑14.9% | 219 | |
| Depreciation & Amortization | 18↓24.5% | 24↓4.4% | 25↓19.3% | 31↑7.3% | 29 | |
| EBITDA | 73↓66.1% | 217↑4.6% | 207↓35.3% | 321↑27.9% | 251 | |
| EBIT | 55↓71.3% | 193↑5.8% | 182↓37.0% | 290↑30.6% | 222 | |
| Interest & Other Income | ||||||
| Net Interest Income | -23↑19.1% | -28↓27.0% | -22↓132.7% | -9↑11.8% | -11 | |
| Interest Income | 8↑148.0% | 3↑1737.1% | 0.18↑263.3% | 0.05↓83.2% | 0.29 | |
| Interest Expense | 31↓1.6% | 31↑40.7% | 22↑133.4% | 10↓13.7% | 11 | |
| Non-Operating Income | 39↑206.6% | -37↓2057.2% | -2↑95.5% | -38↓1361.6% | -3 | |
| Other Income / Expenses | -8↑92.9% | -117↓468.8% | -21↓172.5% | 28↑435.1% | -8 | |
| Income Before Tax | 86↑117.6% | 40↓75.3% | 160↓42.8% | 280↑32.9% | 211 | |
| Income Tax Expense | 48↓5.0% | 51↑18.8% | 43↓39.3% | 70↑173.3% | 26 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 38↑449.0% | -11↓109.3% | 118↓44.0% | 210↑13.5% | 185 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 43↑543.5% | -10↓108.2% | 119↓43.3% | 209↑13.9% | 184 | |
| Bottom-Line Net Income | 43↑543.5% | -10↓108.2% | 119↓43.3% | 209↑13.9% | 184 | |
| EPS (Basic) | 1.32↑540.0% | -0.30↓108.2% | 3.65↓43.1% | 6.41↑13.7% | 5.64 | |
| EPS (Diluted) | 1.31↑536.7% | -0.30↓108.3% | 3.63↓42.7% | 6.34↑14.9% | 5.52 | |
| Weighted Average Shares | 33↑0.7% | 32↓0.1% | 33↓0.4% | 33↑0.3% | 33 | |
| Weighted Average Diluted Shares | 33↑1.4% | 33↓0.2% | 33↓1.0% | 33↓0.9% | 33 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.